Upfront

Indoco gears up for Brazil

Our News Bureau - Mumbai

Indoco Remedies announced that its solid dosage facility at Goa, Plant I has received approval from Brazilian food and drug agency, Anvisa, marking the beginning of company's foray into one of the most favoured pharmaceutical market in the world. This approval paves way for contract manufacturing opportunities for Indoco in Brazil. "As a part of companies' growth strategy and to move up the value chain, Indoco Remedies intends to enter newer, semi-regulated and regulated markets worldwide after getting approvals from the respective regulatory authorities," said Aditi Kare Panandikar, Director Business Development, Indoco Remedies. In addition, Indoco Remedies is working towards obtaining MCC approvals, for their solid dosage as well as sterile plants.